The University of Iowa

State Hygienic Laboratory

Breadcrumb

  1. Home
  2. Testing Specialties
  3. Diagnostic and Clinical Testing

Test Detail


Newborn Screen

Back to Test Directory
Test Description
  • Contact: Newborn Screening (515) 725-1630
  • Test Request Form: Contact the Newborn Screening Lab for collection forms.
  • SHL OpenELIS Code: U80001-AK (Alaska), U80001 (Iowa), U80001-ND (North Dakota), U80001-SD (South Dakota)
Screening for certain genetic, endocrine, and metabolic disorders that can affect a child’s long-term health or survival. Early detection, diagnosis, and intervention can prevent death or disability and enable children to reach their full potential.
Panel Components
49 inherited conditions including Biotinidase Deficiency, Congenital Adrenal Hyperplasia, Congenital Hypothyroidism, CPT1A Arctic Variant (c.1436C>T) (Alaska only), Cystic Fibrosis, Expanded Screening Disorders, Galactosemia, Hemoglobinopathies, MPS1 Disease (Iowa and North Dakota only), Pompe Disease (Iowa, North Dakota, and South Dakota only), Severe Combined Immunodeficiency, Spinal Muscular Atrophy, and X-linked Adrenoleukodystrophy (Iowa and South Dakota only).
Reflex Test(s)
Cystic Fibrosis by Luminex xMAP Technology, Cystic Fibrosis by Sanger Sequencing, Hemoglobinopathies by High Pressure Liquid Chromatography, Mucopolysaccharidosis by Liquid Chromatography-Tandem Mass Spectrometry, Pompe Disease 2ND Tier NBS by Flow Injection Analysis-Tandem Mass Spectrometry
Performed Avg. Turnaround Time Method
Ankeny 24/7
1 - 3 business days Enzymatic Assay, Immunoassay, IRT Immunoassay, Isoelectric Focusing, Real-Time PCR, Tandem Mass Spectrometry
Fee CPT Code(s)
$190.50 (AK), $162.00 (IA), $122.00 (ND), $106.00 (SD) S3620
Specimen Requirements
Specimen Type: Blood spot specimen
Collection Instructions:
  1. Check that the expiration date of the specimen card has not passed. Avoid touching the filter paper before or after blood collection. These instructions are based on the Clinical Laboratory Standards Institute (CLSI) standard NBS01, Dried Blood Spot Collection for Newborn Screening 7th edition.
  2. Warm infant's heel for 3-5 minutes to no more than 42 degrees C to help increase blood flow. Wipe infant's heel with 70% isopropyl alcohol and allow heel to air dry completely.
  3. Select a puncture site from the shaded area as illustrated in the figure below. Use a puncture device that does not exceed 2 mm in depth. A retractable incision device may provide improved blood flow by making a standard incision 1.0 mm deep by 2.5 mm long.
  4. Wipe away the first drop of blood with sterile gauze. Wait for formation of a large blood droplet and gently touch the filter paper card to the blood drop. Do not touch the filter paper to the heel.
  5. Fill each printed circle with a SINGLE application of blood. DO NOT layer successive drops of blood on the target spot. All circles should be completely filled. Blood spots should not touch other spots. Additional blood spots may be added to available space on filter paper.
  6. Avoid practices which could compromise specimen quality and delay testing. DO NOT allow water, formulas, antiseptic solutions, powder from gloves, or other materials to come into contact with filter paper. DO NOT squeeze tissue to obtain blood. DO NOT use devices that contain EDTA or heparin. DO NOT apply blood to both sides of filter paper. DO NOT apply layers of blood to filter paper. DO NOT expose card to heat, moisture, or direct sunlight. DO NOT scratch, bend, fold, or further damage the filter paper. DO NOT stack wet specimens. DO NOT hold specimens for batch shipping.
  7. Allow blood specimen to air dry at room temperature in a flat horizontal position on clean surface or in a drying rack for at least three hours, or until completely dry.
  8. Prepare and package specimens for shipping to the laboratory within 24 hours of collection. Do not hold specimen for batch shipping. Courier pick up occurs 365 days a year.

Call the Newborn Screening laboratory at 515-725-1630 to obtain a copy of this document or to get assistance in collection of the newborn screen specimen.

Shipping:
Ship a fully dried specimen in an envelope at 15-30°C (do not use plastic). Send via courier (preferred). If courier information or setup is required, please contact shl-courier@uiowa.edu or call 319-335-1143. If courier delivery is not available mail specimens overnight to: Iowa Newborn Screening Program, State Hygienic Laboratory, 2220 S. Ankeny Blvd., Ankeny, IA 50023-9093. If courier and overnight are not available mail specimens to: Iowa Newborn Screening Program, State Hygienic Laboratory, P.O. Box 249, Ankeny, IA 50021-0249.
Temperature and Stability: Room temperature; submit specimen within 24 hours of collection.
Rejection Criteria: Specimens will be rejected if received under these conditions:

Blood exhibiting layering, clotting, insufficient quantity, dilution, contamination, serum separation, applied to both sides of the filter paper, or didn't fully saturate through the filter paper. Sample collected on a damaged or expired filter paper collection device. Sample received at SHL more than 14 days after the sample was collected.
Expected Results:
Within Normal Limits, Presumptive Positive - Program staff will contact with recommendations, Presumptive Positive - Program staff will contact for second tier testing, Borderline - Resubmit newborn screen sample, Borderline - Program staff will contact with recommendations, Borderline - Sample has been sent for second tier testing, Borderline - Program staff will contact for second tier testing, Poor Quality - Resubmit newborn screen sample, Early Collection - Resubmit newborn screen sample, Early Collection Unknown - Provide missing information, Transfused - Program staff will contact with recommendations, Transfused Unknown - Provide missing information, Inconclusive - Resubmit newborn screen sample, Unknown Weight - Elevated - Provide missing information, Possible Cystic Fibrosis - Program staff will contact with recommendations, Indeterminate results due to possible transfusion - Program staff will contact for clarification, numerous abnormal Hemoglobinopathies interpretations, Indeterminate - Program staff will contact with recommendations, Indeterminate - Resubmit newborn screen sample, Indeterminate with prior normal. No further action needed. Indeterminate due to Prematurity - Program staff will contact with recommendations, Abnormal Analyte - Program staff will contact with recommendations, Age at Collection Unknown - Provide missing information, Negative, Indeterminate - Arctic Variant, Homozygous-CPT1A Arctic Variant
Comments

This is a screening test and not indicated for stand-alone purposes; results should be used in conjunction with other available laboratory and clinical information. A false negative or a false positive result must always be considered when screening; therefore, clinical findings and status should be considered whenever interpreting laboratory results. Newborn reference values may not be applicable to older infants, thus screening results should be interpreted with caution in such cases.

Information on the conditions screened is available at:

  • Alaska: https://shl.uiowa.edu/diagnostic-and-clinical-testing/newborn-screening
  • Iowa: https://hhs.iowa.gov/programs/programs-and-services/family-health/congenital-inherited-disorders/iowa-newborn-screening-program/iowa-newborn-screening-education/blood-spot-screening-information
  • North Dakota: https://www.hhs.nd.gov/cfs/newborn-screening/newborn-blood-spot-screening/information-parents/disorders
  • South Dakota: https://doh.sd.gov/programs/newborn-screening/blood-spot/disorders/?pvs=21
The University of Iowa

State Hygienic Laboratory

General inquires
SHL Client Services
319-335-4500 or 1-800-421-IOWA (4692)
ask-shl@uiowa.edu

Footer primary

  • HIPAA Notice of Privacy Practice
  • Copyright 2025 The University of Iowa
  • Privacy Notice
  • UI Nondiscrimination Statement
  • Accessibility